Searching for new strategies against prostate cancer
Freiburg Scientist Roland Schüle is awarded EU funding of €2.5 million for research on epigenetic mechanisms.
The European Research Council (ERC) has announced that Roland Schüle, Scientific Director at the Department of Urology, University of Freiburg Medical Centre has been awarded an ERC Advanced Grant.
Professor Schüle will receive €2.5 million for a period of 5 years for his research proposal to identify and characterize the molecular and physiological functions of the epigenetic enzyme LSD1 and to explore its role in prostate cancer.
“I am absolutely delighted to receive this significant research award” says Roland Schüle. “This is an acknowledgement of both, the quality of the research proposal as well as a recognition of the excellent science which my team has generated over the last years.” The proposed research will explore the role of the epigenetic regulator lysine-specific demethylase 1 (LSD1).
LSD1 is an enzyme that has been identified by the Schüle lab as a histone demethylase with important functions in the onset and proliferation of prostate cancer. “This 5-year funding will allow us to establish the molecular functions of LSD1 by using disease models and high-throughput genomic approaches. This may lead to novel therapeutic and diagnostic concepts for prostate cancer.”
The ERC Advanced Grant complements the recently established Collaborative Research Centre Medical Epigenetics (CRC MEDEP), a consortium of about 20 Freiburg-based investigators who determine the potential of epigenetics in medical applications. Roland Schüle is also coordinator of the CRC MEDEP.
The ERC Advanced grant is one of the most prestigious research grants awarded to individual scientists within Europe. The grant is awarded to excellent researchers who already have a track record of significant research achievements and who have worked for at least ten years successfully at the highest international level. The evaluation process takes into consideration the scientific achievements of the applicant as well as the specific research project submitted. The grants are awarded based entirely on the scientific quality of the applications.
Prof. Dr. Roland Schüle
Scientific Director Department of Urology
University of Freiburg Medical Center
Department of Urology/Women's Hospital and Center for Clinical Rese-arch
Doreen Winkler | idw
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Mapping the interaction of a single atom with a single photon may inform design of quantum devices
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...